We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current KYTX market cap is 647.85M. The company's latest EPS is USD -1.4787 and P/E is -10.72.
Quarter End | |||
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | |||
Operating Income | |||
Net Income |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.66M | 7.03M | 0 |
Operating Income | -26.35M | -29.38M | -62.41M |
Net Income | -26.35M | -28.89M | -60.37M |
Quarter End | |||
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | |||
Total Liabilities | |||
Total Equity |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 85.49M | 66.92M | 75.2M |
Total Liabilities | 23.02M | 20.25M | 26.02M |
Total Equity | -46.25M | -74M | -131.4M |
Market Cap | 647.85M |
Price to Earnings Ratio | -10.72 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 18.68 |
Price to Book Ratio | 13.16 |
Dividend Yield | - |
Shares Outstanding | 40.82M |
Average Volume (1 week) | 347.25k |
Average Volume (1 Month) | 450.11k |
52 Week Change | -53.66% |
52 Week High | 35.01 |
52 Week Low | 12.26 |
Spread (Intraday) | 5.21 (27.48%) |
Company Name | Kyverna Therapeutics Inc |
Address |
3500 s dupont hwy dover, delaware 19901 |
Website | https://kyvernatx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions